Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade F 0.28 -3.45% -0.01
AYTU closed down 3.45 percent on Thursday, July 19, 2018, on 27 percent of normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical AYTU trend table...

Date Alert Name Type % Chg
Jul 19 Bollinger Band Squeeze Range Contraction 0.00%
Jul 19 Outside Day Range Expansion 0.00%
Jul 18 Bollinger Band Squeeze Range Contraction -3.45%
Jul 18 BB Squeeze Started Range Contraction -3.45%
Jul 17 Wide Bands Range Expansion 3.70%
Jul 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.45%
Jul 16 Outside Day Range Expansion -3.45%
Jul 16 Wide Bands Range Expansion -3.45%
Jul 13 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.11%
Jul 13 Narrow Range Bar Range Contraction -3.11%

Older signals for AYTU ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Is AYTU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.82
52 Week Low 0.23
Average Volume 1,880,376
200-Day Moving Average 0.0
50-Day Moving Average 0.3252
20-Day Moving Average 0.2866
10-Day Moving Average 0.2859
Average True Range 0.0343
ADX 9.61
+DI 18.1518
-DI 24.2368
Chandelier Exit (Long, 3 ATRs ) 0.2371
Chandelier Exit (Short, 3 ATRs ) 0.3329
Upper Bollinger Band 0.3241
Lower Bollinger Band 0.2491
Percent B (%b) 0.41
BandWidth 26.168877
MACD Line -0.0152
MACD Signal Line -0.0191
MACD Histogram 0.0039
Fundamentals Value
Market Cap 1.13 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.01
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.33
Resistance 3 (R3) 0.33 0.31 0.32
Resistance 2 (R2) 0.31 0.30 0.31 0.32
Resistance 1 (R1) 0.30 0.29 0.29 0.30 0.31
Pivot Point 0.28 0.28 0.28 0.28 0.28
Support 1 (S1) 0.26 0.27 0.26 0.26 0.25
Support 2 (S2) 0.25 0.26 0.25 0.24
Support 3 (S3) 0.23 0.25 0.24
Support 4 (S4) 0.23